Killing of Leishmania tropica amastigotes by factors in normal human serum
- PMID: 6690622
Killing of Leishmania tropica amastigotes by factors in normal human serum
Abstract
Amastigotes of Leishmania tropica and L. donovani were incubated with fresh or heat-inactivated normal human serum. Viability was estimated by amastigote conversion to promastigote forms and by the ability of serum-treated amastigotes to infect human monocytes. L. tropica, a parasite that causes local skin infection, was killed by fresh but not by heat-inactivated serum. The serum cytotoxic effect on L. tropica was inhibited by EDTA but not by Mg-EGTA. C2-deficient serum killed normally; C6-deficient serum was ineffective. These data indicate that L. tropica is killed by the complement membrane attack complex, in a sequence of reactions initiated by components of the alternate pathway. In contrast, L. donovani, a parasite that causes systemic visceral leishmaniasis, was 10-fold less susceptible to the cytotoxic effects of normal serum. Thus, a profound difference exists in the susceptibility of amastigotes of two species of Leishmania to a defense mechanism present in human serum. Serum complement factors may play an important role in limiting L. tropica to the skin. The resistance of L. donovani to such factors may be the primary reason for its ability to escape from the site of inoculation and cause catastrophic, disseminated disease.
Similar articles
-
Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.J Immunol. 1984 Jun;132(6):3120-5. J Immunol. 1984. PMID: 6725948
-
Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.J Immunol. 1985 Jul;135(1):570-4. J Immunol. 1985. PMID: 3998474
-
Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.J Immunol. 1984 Mar;132(3):1501-5. J Immunol. 1984. PMID: 6363545
-
[Leishmaniasis: effect of factors present in serum].G Batteriol Virol Immunol. 1990 Jan-Dec;83(1-12):118-24. G Batteriol Virol Immunol. 1990. PMID: 2133319 Review. Italian.
-
Chemokines in host-parasite interactions in leishmaniasis.Trends Parasitol. 2006 Jan;22(1):32-40. doi: 10.1016/j.pt.2005.11.010. Epub 2005 Nov 23. Trends Parasitol. 2006. PMID: 16310413 Review.
Cited by
-
Innate immunity against Leishmania infections.Cell Microbiol. 2015 Sep;17(9):1286-94. doi: 10.1111/cmi.12484. Epub 2015 Aug 11. Cell Microbiol. 2015. PMID: 26249747 Free PMC article. Review.
-
Cutaneous Leishmaniasis: The Complexity of Host's Effective Immune Response against a Polymorphic Parasitic Disease.J Immunol Res. 2019 Dec 1;2019:2603730. doi: 10.1155/2019/2603730. eCollection 2019. J Immunol Res. 2019. PMID: 31871953 Free PMC article. Review.
-
How Structures of Complement Complexes Guide Therapeutic Design.Subcell Biochem. 2021;96:273-295. doi: 10.1007/978-3-030-58971-4_7. Subcell Biochem. 2021. PMID: 33252733 Review.
-
Complement in the Initiation and Evolution of Rheumatoid Arthritis.Front Immunol. 2018 May 28;9:1057. doi: 10.3389/fimmu.2018.01057. eCollection 2018. Front Immunol. 2018. PMID: 29892280 Free PMC article. Review.
-
Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.Infect Immun. 1985 Oct;50(1):1-8. doi: 10.1128/iai.50.1.1-8.1985. Infect Immun. 1985. PMID: 3930401 Free PMC article.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous